Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ward

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|March 16, 2021
Quantification of biomarker functionality predicts patient outcomesBanafshé Larijani, James Miles, Stephen G Ward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxisDarran G Cronshaw, Charles Owen, Zarin Brown, et al.
The Journal of Biological Chemistry|December 13, 2007
Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytesStephanie J Harris, Richard V Parry, John Westwick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinasesAdam P Curnock, Yannis Sotsios, Karen L Wright, et al.
Trends in Molecular Medicine|July 1, 2009
Cdx genes, inflammation and the pathogenesis of Barrett's metaplasiaBenjamin J Colleypriest, Rebecca M Palmer, Stephen G Ward, et al.
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
International Immunopharmacology|February 6, 2007
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxisKaren Coopman, Laura D Smith, Karen L Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2006
Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: Role in osmoprotective transcriptional regulationCarlos E Irarrazabal, Maurice B Burg, Stephen G Ward, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic useEdward Carter, Chun Yin Lau, David Tosh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
Hydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte MigrationJennifer A Ball, Isabella Vlisidou, Matthew D Blunt, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|March 16, 2021
Quantification of biomarker functionality predicts patient outcomesBanafshé Larijani, James Miles, Stephen G Ward, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxisDarran G Cronshaw, Charles Owen, Zarin Brown, et al.
The Journal of Biological Chemistry|December 13, 2007
Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytesStephanie J Harris, Richard V Parry, John Westwick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinasesAdam P Curnock, Yannis Sotsios, Karen L Wright, et al.
Trends in Molecular Medicine|July 1, 2009
Cdx genes, inflammation and the pathogenesis of Barrett's metaplasiaBenjamin J Colleypriest, Rebecca M Palmer, Stephen G Ward, et al.
Pharmacological Reviews|October 2, 2012
Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignanciesJohn G Foster, Matthew D Blunt, Edward Carter, et al.
International Immunopharmacology|February 6, 2007
Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxisKaren Coopman, Laura D Smith, Karen L Wright, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2006
Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: Role in osmoprotective transcriptional regulationCarlos E Irarrazabal, Maurice B Burg, Stephen G Ward, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 21, 2013
Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic useEdward Carter, Chun Yin Lau, David Tosh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2017
Hydrogen Peroxide Triggers a Dual Signaling Axis To Selectively Suppress Activated Human T Lymphocyte MigrationJennifer A Ball, Isabella Vlisidou, Matthew D Blunt, et al.
Pageof 7